Seres Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MCRB and other ETFs, options, and stocks.About MCRB
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401.
CEOThomas J. DesRosier
CEOThomas J. DesRosier
Employees103
Employees103
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees103
Employees103
MCRB Key Statistics
Market cap120.46M
Market cap120.46M
Price-Earnings ratio-1.74
Price-Earnings ratio-1.74
Dividend yield—
Dividend yield—
Average volume97.05K
Average volume97.05K
High today$15.34
High today$15.34
Low today$13.75
Low today$13.75
Open price$15.13
Open price$15.13
Volume169.04K
Volume169.04K
52 Week high$24.67
52 Week high$24.67
52 Week low$6.53
52 Week low$6.53
Stock Snapshot
The current Seres Therapeutics(MCRB) stock price is $13.75, with a market capitalization of 120.46M. The stock trades at a price-to-earnings (P/E) ratio of -1.74.
During the trading session on 2025-11-05, Seres Therapeutics(MCRB) shares reached a daily high of $15.34 and a low of $13.75. At a current price of $13.75, the stock is 0.0% higher than the low and still -10.4% under the high.
Trading activity shows a volume of 169.04K, compared to an average daily volume of 97.05K.
Over the past 52 weeks, Seres Therapeutics(MCRB) stock has traded between a high of $24.67 and a low of $6.53.
Over the past 52 weeks, Seres Therapeutics(MCRB) stock has traded between a high of $24.67 and a low of $6.53.
People also own
Based on the portfolios of people who own MCRB. This list is generated using Robinhood data, and it’s not a recommendation.